Abstract Details

Title Dabrafenib in Erdheim-Chester Disease of the cerebellum induces remission.

Topic Neuro-oncology

Presentation(s) P3 - (-)

Poster/Presentation
Number 150

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ahmad El Kouzi, MD, FAAN PRESENTER	Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Ali K. Choucair, MD	No disclosure on file
Paula Rauschkolb, DO (Anthem Neurology)	No disclosure on file
James M. Gilchrist, MD, FAAN (Southern Illinois University School of Medicine)	Dr. Gilchrist has received publishing royalties from a publication relating to health care.

��ɫ����